Hint mode is switched on Switch off
For swift navigation between sections

Veraxa Biotech Holding

PDF download

Choose all Reset all
Download Cancel
Organization name
Veraxa Biotech Holding AG
Country name
Switzerland
Country of registration
Switzerland
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Veraxa Biotech AG is a Switzerland-based company. The Company is primary engaged in biotechnology, advancing innovations in the field of antibody development and microfluidic technologies. The Company’s activities center on participating in and supporting businesses engaged in the screening of diagnostic and therapeutic antibodies, as well as their chemical or recombinant modification, formatting, validation, and preclinical and clinical development. In addition, the Company is involved in the commercialization and marketing of such solutions both domestically and internationally. The Company operates mainly through investments and strategic management of affiliated entities, providing services and oversight to companies within its portfolio.

Awards

News

27/05/2026 Voyager Acquisition: Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of A Registrant, Unregistered Sale Of Equity Securities, Regulation Fd Disclosure, Financial Statements And Exhibits
12/03/2026 Voyager Acquisition: Submission Of Matters To A Vote Of Security Holders, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
05/09/2025 Voyager Acquisition: Regulation Fd Disclosure, Financial Statements And Exhibits
16/07/2025 Voyager Acquisition: Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
22/04/2025 Voyager Acquisition: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
IV q eng
2024
II q eng
III q eng
IV q eng
Show more Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0002079109
Registration is required to get access.